explore -WSS

explore

author：knowledge 2025-10-01 11:02:41 - browse：685

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Most antidepressants don't work on kids, teens, study finds

knowledge

Wikipedia

WSS

Lawmakers grill UnitedHealth CEO on Change cyberattack

Senators: Long

Has Bernie Sanders reached the limit of his pharma bullying effort?

Chemotherapy before breast cancer surgery might fuel metastasis

Has Bernie Sanders reached the limit of his pharma bullying effort?

CDC's new outbreak response network to include Northeastern

knowledge

explore

explore

Cancer drug shortages should be causing more outrage

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Supreme Court strikes down use of affirmative action

CommonSpirit Health keeps growing, even as it loses money

BioMarin wins approval for gene therapy to treat hemophilia A

CDC advisers recommend seasonal use of Pfizer RSV shot

In Memoriam: Notable people who died in 2023

Lawmakers grill UnitedHealth CEO on Change cyberattack

ChatGPT in medicine: STAT answers readers' burning questions

BIO to announce reorganization, senior leaders expected to depart

entertainment

Brain MRIs reveal impact of 'toxic stress' on Black children

Warren pushes Witty on UnitedHealth's control over physicians

Deliver public health messages at the right time

Brain MRIs reveal impact of 'toxic stress' on Black children

As health system earnings go up, health insurance stocks go down

Changes to biosimilar regulatory framework must prioritize patients

Wikipedia

knowledge

Wikipedia

focus